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Telomeres and Telomerase: Meeting Review
A Simple Picture
Becomes Complex
Victoria Lundblad* and Woodring E. Wright† the recent cloning of the first two protein subunits of
telomerase (Collins et al., 1995). In contrast, in other*Department of Molecular and Human Genetics
organisms where the enzyme has been less abundantBaylor College of Medicine
and/or recalcitrant to standard purification techniques,Houston, Texas 77030
our current knowledge is much more limited. As a result,†Department of Cell Biology and Neuroscience
although the gene encoding the RNA subunit has beenUniversity of Texas Southwestern Medical Center
recovered from yeast to mice to humans, cloning ofDallas, Texas 75234
telomerase protein components from these species has
so far remained elusive.
However, two molecular advances have provided val-
Eighteen years ago, Elizabeth Blackburn and Joe Gall uable tools for dissecting the multiple levels of regula-
described an unusual repeated sequence motif present tion that occur during telomere length maintenance in
at chromosomal termini in the ciliate Tetrahymena mammalian systems. The first of these was a substantial
(Blackburn and Gall, 1978). This discovery provided the technological improvement in the ability to monitor hu-
first molecular entry point into the study of the special- man and mouse telomerase activity, with the develop-
ized chromosomal structures called telomeres. Over the ment of a highly sensitive PCR-based assay (Kim et
last ten years, there has been an explosion of interest al., 1994). This so-called TRAP assay, and subsequent
in the field of telomere biology, with the discovery of a improvements, has allowed semi-quantitative measure-
novel DNA polymerase responsible for replicating chro- ments of telomerase activity in sample sizes as small
mosomal termini as well as the more recent tantalizing as 100 cells. The second was the cloning last year of
connections between telomere length maintenance and both the mouse and human telomerase RNA subunits
cellular proliferation during oncogenesis. A recent meet- (mTR and hTR, respectively; Feng et al., 1995; Blasco
ing, the Geron Telomerase and Cancer Symposium (Au- et al., 1995). These two steps have allowed detailed
gust 10–14, Kamuela, Hawaii), provided an opportunity molecular investigation of an observation first made by
for a wide range of scientists with interests in both basic Cooke and Smith (1986), and later elaborated by Harley
et al. (1990), that telomere length declines in normalbiology as well as clinical applications to focus on the
human somatic cells and may therefore contribute torecent advances that have occurred in the last year.
cellular senescence. This led to the proposal that telo-This meeting report summarizes the highlights, as well
mere shortening may be the molecular mechanism re-as the upcoming issues and problems attracting current
sponsible for the so-called “mitotic clock” that dictatesattention.
the number of cellular divisions a normal cell line canSince the discovery that the sequence GGGGTT is
undergo. The availability of a highly sensitive assay forrepeated at Tetrahymena termini, all but a few eukary-
telomerase has demonstrated that this enzyme is indeedotes have been shown to have telomeres that closely
present in the human germ line but absent in most nor-conform to the motif of a repetitive G-rich sequence
mal somatictissues. Whether this differential expression(reviewed by Henderson, 1995). For most organisms,
contributes to control of cellular proliferation in normalthe number of repeats is somewhat variable, resulting
cells in vivo is yet to be determined, but minimally thesein telomere length heterogeneity. In addition, from spe-
data indicate that there must be stringent mechanism(s)cies to species, there can be striking contrasts in telo-
to developmentally repress telomerase activity.mere tract length, with telomeres shorter than 50 bp in
A corollary of this proposal is that the sustained cellu-the hypotrichous ciliates but as long as 50 kb in one
lar proliferation necessary for tumor progression wouldspecies of mice. A primary determinant for dictating
also involve regulation of telomerase as a means oftelomere length is a DNA polymerase specific for the
maintaining the terminus. The TRAP assay has made it
telomeres called telomerase (reviewed by Greider,
feasible to assess telomerase activity in a large number
1996). This enzyme uses a novel mode of synthesis in
of tumor biopsies, and the striking result has been that
that the information dictating the sequence of the prod- although telomerase is absent (or greatly reduced) in
uct is present in the form of a telomerase RNA subunit; most somatic tissues, z90% of primary human malig-
the region of the RNA that templates these repeats is nancies are positive for the enzyme (Kim et al., 1994).
short, consisting of roughly one and a half telomeric This suggests not only that telomerase may be useful as
repeats. Telomerase has now been identified biochemi- a new marker for malignancy butalso that reactivation of
cally from a wide range of sources; however, although telomerase may be crucial for tumor proliferation (de
the enzyme appears to be ubiquitously distributed Lange, 1994; Harleyet al., 1995). Supporting this hypoth-
throughout the eukaryotic kingdom, it has not proven esis is the demonstration that both the mouse and hu-
to be equally abundant from all sources. Since ciliates man telomerase RNAs are up-regulated in immortal can-
such as Tetrahymena and Euplotes have a develop- cer cell lines and during tumor development (Feng et
mental stage during their life cycle that necessitates the al., 1995; Avilion et al., 1996; Blasco et al., 1996; Broccoli
de novo synthesis of 106 to 107 new telomeres, these et al.,1996). As a consequence, a number of laboratories
organisms have provided the best initial sources of telo- are currently developing inhibitors of telomerase activity
merase. As a consequence, much of what we know as prospective anti-cancer therapeutics.
about this DNA polymerase at a molecular level comes A second important class of genes involved in telo-
mere biology has been the class of genes encoding thefrom these workhorses of the telomere field, including
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proteins that bind the duplex and single-strand regions that also have altered telomeric sequences results in
of the telomere and contribute to theunique non-nucleo- completely unregulated telomere elongation, whereas
somal chromatin structure called the telosome. The first either mutant situation alone has only minor effects on
well-characterized telomere proteins, from the ciliates telomere length regulation.
Oxytricha and Euplotes, have been shown to bind tena- The paradigm of a negative regulator of telomere elon-
ciously to the G-rich single-strand extension found at gation was further underscored by experiments from the
the end of the chromosome (reviewed by Fang and fission yeast, S. pombe. T. Cech (University of Colorado,
Cech, 1995). In addition to these end-binding factors Boulder) described a novel protein called taz1 (for telo-
are the proteins that bind to the duplex portion of the mere associated in Schizosaccharomyces pombe),
chromosome, best characterized in S. cerevisiae. As which was recovered from a one hybrid screen using S.
components of telomeric chromatin, the yeast duplex pombe telomeric sequences linked to a reporter gene.
telomere-binding protein Rap1 and its associated fac- Deletion of taz1 disrupts the non-nucleosomal chroma-
tors have been shown to play key roles in telomere tin structure normally present at wildtype telomeres and
length regulation. However, a gene identification bottle- dramatically enhances the expression of a telomere-
neck similar to that for telomerase has also occurred proximal reporter gene, normally subject to transcrip-
for telomere binding proteins, in that the ciliate and S. tional repression in taz11 cells (referred to as telomere
cerevisiae genes did not readily lead to the identification position effect). The absence of taz1 function and the
of their mammalian counterparts. A critical step inbreak- resulting disruption of telomeric chromatin also results
ing this bottleneck came last year with the cloning of a in unregulated telomere elongation, with telomeres in-
human gene called TRF (Telomere Repeat Factor), using creasing in length by at least ten-fold. Intriguingly, taz12/
a biochemical rather than a molecular approach (Chong taz12 diploids also display a meiotic defect as mani-
et al.,1995). TRF protein binds with high sequence spec- fested by a substantial decline in spore viability as well
ificity to human duplex telomeric DNA and localizes in as an alteration in spore morphology. This may provide
vivo to the telomere; by analogy with Rap1, it should be a molecular basis for understanding telomere-led chro-
similarly involved in telomere length regulation. As the mosome movement that occurs during S. pombe pre-
first mammalian protein involved in telomere biology, meiosis (Chikashige et al., 1994); Taz1 (or Taz1-associ-
this should now allow rapid identification of associated ated factors) may mediate chromosome association
proteins involved at the telomere. These three mamma- and/or recombination during the steps leading to
lian telomere genes (TRF, hTR, and mTR) have also pro- meiosis.
vided the first opportunities for comparisons with telo- These observations in budding and fission yeast have
mere length maintenance in model organisms. One of led both laboratories to propose that components of
the themes of the meeting was that although fundamen- telomeric chromatin wrap the telomere up into a struc-
tal concepts for telomere biology hold true from ciliates tured complex, thereby preventing unlimited access of
to yeast to humans, the regulation of telomere length in telomerase to the telomere. The flip side of the coin
multicellular organisms is revealing unexpected com- is the question of whether there are factors that are
plexities. necessary to load telomerase onto the chromosomal
terminus. V. Lundblad (Baylor College of Medicine,
Houston, Texas) described a genetic search for telo-Telomerase Regulation: Insights
merase-defective mutants of budding yeast that led tofrom Model Organisms
the identification of four S. cerevisiae genes that areGenetic forays into both the budding and fission yeasts
required in vivo for telomerase function but dispensablehave recently revealed a wealth of information about
in vitro for enzymatic activity. A possible explanation fornegative and positive regulation of telomerase activity.
this apparent contradiction came from the demonstra-In the budding yeast K. lactis, alterations in the se-
tion that two of the genes identified in this screen, EST1quence of the telomeres, via changes in the template
and CDC13, encode single-strand telomere DNA–region of the telomerase RNA, had previously been
binding proteins. This class of telomere-binding pro-shown to result in dramatic increases in telomere
teins, primarily characterized in the ciliates, had pre-lengths. McEachern and Blackburn (1995) had proposed
viously been proposed to protect the telomere fromthat these altered telomeres resulted in the loss of telo-
degradation. Indeed, prior work from Hartwell’s labmere-binding proteins, permitting unregulated access
showing a critical role for CDC13 inmaintaining telomereof telomerase to the chromosomal terminus. One likely
integrity is consistent with a protective function (Garvikcandidate for a K. lactis telomere length regulator is
et al., 1995). However, the characterization of a novelthe duplex DNA–binding protein Rap1 described above.
cdc13 mutation with a telomerase-like defect in this newConsistent with this prediction, E. Blackburn (University
screen led to the model that Cdc13p also provides, inof California, San Francisco, California) showed that
collaboration with Est1p, a docking site for telomerasetelomere sequence alterations that lead to runaway telo-
at the end of the chromosome, such that loss of thismere elongation in K. lactis also disrupt the Rap1 con-
activity via mutation in either gene results in a telo-sensus site, with a loss of K. lactis Rap1 binding activity
merase-minus phenotype.to mutated telomeric sequences that is proportional to
Thus, factors bound to the single-strand extensionthe loss of length regulation observed in vivo. Further-
present at the extreme end of the chromosome can playmore, the combination of mutant telomeres and a par-
several roles in telomere maintenance, one of which maytially defective Rap1 protein produces a striking syner-
gistic effect: deletion of the Rap1 C-terminus in strains be tomediate telomerase access. Onemore observation
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from the K. lactis system indicates that negative regula- complex), RF-A, and RF-C complexes share a number
tion of this enzyme may also occur primarily at the chro- of recognizable motifs between the human proteins and
mosomal terminus. In the completely unregulated pro- their yeast counterparts, with generally about 30% se-
cess of telomere elongation that occurs in the double quence identify between the two organisms for these
mutant strain described above, with a defective Rap1p sets of genes.
and mutant telomeric repeats, reintroduction of one or One limited point of similarity between hTRF and Taz1
more wildtype telomeric repeats at the terminus pre- is the presence of one copy of the Myb proto-oncogene
vents further lengthening (E. Blackburn). This indicates DNA binding motif in the C-terminus of each of these
that Rap1 occupancy at the most distal duplex portion two proteins (Chong et al., 1995; T. Cech). Although the
of the telomere iscritical for its role in limiting telomerase S. cerevisiae Rap1 protein has no recognizable Myb
entry, and also suggests the possibility of cross-talk domains at the primary sequence level, the recently
between Rap1 (and Rap1-associated factors) and pro- solved crystal structure of the Rap1 DNA binding frag-
teins bound to the single-strand extension, such as ment revealed two domains with structural similarity to
Cdc13 and Est1. the Myb motif (Konig et al., 1996). Myb-containing pro-
teins require a minimum of two Myb repeats to bind DNA
A Theme of Functional Conservation Only and the Rap1 DNA binding domain also has a bipartite
The G-rich telomeric repeat tract exhibits striking se- organization, raising the question of how proteins such
quence similarities across the eukaryotic kingdom, with as hTRF and Taz1, each with a single Myb motif, func-
many evolutionary diverse species displaying the same tion. In the case of hTRF, this was resolved via the
or highly related sequences at the telomere. In every demonstration that hTRF dimerizes and thereby also
case examined to date, these G-rich telomeric repeats uses two Myb-type repeats to bind DNA (T. de Lange).
have been shown to be synthesized by telomerase, al- A further extension of the concept of the yeast and
ways using a RNA-templated mechanism. Molecular human proteins as functional analogs is the demonstra-
analysis of components of both telomerase and telo- tion that hTRF creates a bend of 1208 in DNA (T. de
meric chromatin has now made it possible to ask Lange), similar to that observed for Rap1. The ability to
whether this functional economy reflects a similar con- bend DNA raises the possibility of an architectural role
servation of the various factors. Comparison of the for these nuclear matrix proteins in telomere packaging.
genes encoding the RNA subunit of telomerase from a
number of distantly related species had revealed little
sequence identity but a common secondary structure, Complexities in Mammalian Telomere
similar to what had also been observed for RNA compo- Length Regulation
nents of many (although not all) other RNPs. Surpris- As is almost always the case in newly emerging fields,
ingly, however, the proteins that act at the telomere are the striking difference between telomerase activity in
not recognizable homologs of each other, even though cancer cells versus normal cells was initially dealt with
they display substantial functional similarity. The se- as an all-or-none phenomenon. There is now compelling
quence of the first protein components of telomerase
evidence that telomerase activity is regulated at multiple
became available last year (Collins et al., 1995), appro-
levels in mammalian cells. As discussed above, both
priately from the ciliate Tetrahymena, where enzyme
double-strand and single-strand telomere binding pro-
activity was first identified (Greider and Blackburn,
teins mediate access of telomerase to the chromosomal1985). Perhaps not unexpectedly, these first telomerase
terminus and are important contributors to telomereproteins did not identify other genes in the database.
length regulation in organisms that are constitutivelyHowever, the sequence of two protein subunits from
telomerase-positive. A number of speakers presentedanother ciliate (evolutionarily distant from Tetrahymena)
data indicating that in humans there must be multiplehas now been completed, and no identifiable conserved
layers of complexity in which telomerase is controlledmotifs can be observed between these two sets of telo-
by at least several different pathways that alter its activ-merase proteins (T. Cech). This lack of sequence similar-
ity and/or expression as a function of cell cycle, growth,ity has important implications for the ease with which
and development.additional telomerase components from other organ-
The use of several different cell culture model systemsisms, including humans, will be isolated; the absence
demonstrated that telomerase activity undergoes sub-of conserved protein domains argues that extending the
stantial regulation upon entry or exit from the cell cycle.set of cloned telomerase protein subunits is not going
Large increases in both telomerase activity and steadyto be trivial. In a similar vein, there is no detectable
state hTR RNA levels are observed as normal human Tconservation between theyeast and ciliate single-strand
cells progress from G0 to S phase, and although telo-telomere binding proteins, even in their DNA binding
merase is activated around the start of S phase, induc-domains (V. Lundblad), and the three duplex telomere
tion does not require DNA synthesis (K. Buchovich, Coldbinding proteins (hTRF, Rap1, and Taz1) have very lim-
Spring Harbor, New York; C.-P. Chiu, Geron Corpora-ited sequence similarity (Chong et al., 1995; T. Cech). In
tion, Menlo Park, California). In contrast, in actively cy-fact, substantial divergence has occurred even between
cling cells, telomeraseactivity does not vary in G1 versusthe mouse and human TRF proteins, with as little as
S versus G2/M stages of the cell cycle, as observed for40% sequence identity in some regions (T. de Lange,
both normal T lymphocytes (N.-P. Weng, ExperimentalRockefeller University, New York). These observations
Immunology Branch/National Cancer Institute, Nationalcontrast sharply with that observed for other multisub-
Institutes of Health, Bethesda, Maryland) as well as forunit complexes involved in chromosomal DNA replica-
tion: protein subunits of ORC (the origin recognition immortal human cell lines (S. Holt, University of Texas
Cell
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Southwestern Medical Center, Dallas, Texas). This was revealed by analysis of the telomere dynamics of
subclones of two human immortal telomerase-positiveraises the question of whether chromosomal termini are
also equally accessible to telomerase during all stages cell lines (HeLa and 293). T. Bryant (Children’s Medical
Research Institute, New South Wales, Australia) showedof the cell cycle. For example, cell-cycle regulation of
the mammalian equivalents of the positive and negative that subclones of these immortal lines could be identi-
fied that lacked telomerase and exhibited telomereyeast regulators may determine when telomerase acts.
Modification of the terminus could also play a role: anal- shortening immediately after subcloning but which sub-
sequently reactivated telomerase; next-generation sub-ysis of the substrate specificity of enzyme from Tetrahy-
mena (Greider and Blackburn, 1987) and Euplotes (T. clones showed the same fluctuation between enzyme
levels in the on and off states. The extraordinarily highCech) demonstrated that telomerase cannot act on a
blunt end, requiring a minimum of a four nucleotide percentage of temporarily telomerase-negative sub-
clones indicates that there is a highly dynamic processoverhang (T. Cech), consistent with predictions for an
in vivo requirement for a 39 overhang for telomerase of telomerase repression, which could provide an expla-
nation for the phenomenon of clonal attenuation docu-function (Lingner et al., 1995). This structure may be
generated in mammalian cells in a cell-cycle–regulated mented several decades ago (Martinez et al., 1978). Re-
versible repression may also contribute to the processmanner via a telomerase-independent mechanism, simi-
lar to that proposed to occur in yeast (Wellinger et al., of maintaining stable telomere length in these cell lines,
but it remains to be determined whether this is the nor-1996).
Just as telomerase is tightly regulated during entry mal pattern used to regulate telomere length in verte-
brates, or whether this represents an abnormal eventinto the cell cycle, many proliferating immortal cells re-
press telomerase when they become quiescent. This resulting from the particular mutation(s) that have oc-
curred in these tumor cells as part of the process byrepression can be reversible if quiescence is achieved
by mechanisms such as confluence or serum depriva- which they became immortal. For example, if the factors
involved in telomerase repression are subject to genetion, or permanent if G0 is attained following differentia-
tion to a post-mitotic state (S. Holt). Interestingly, the dosage effects, the dynamic nature of this repression
could be a consequence of fluctuations in chromosomeassociation of G0 with telomerase repression does not
appear to be uniform, since the basal cells of the pros- ploidy that might occur in subpopulations of immortal
cells.tate in the castrated rat appear to be non-dividing but
stay telomerase-positive for years (A. Meeker, Johns Although telomerase RNA levels increase during tu-
mor development, recent observations have shown thatHopkins University, Baltimore, Maryland), and some tu-
mor lines may also exhibit telomerase activity after dif- induction of the RNA component does not tightly corre-
late with increases in enzyme activity, suggesting a sep-ferentiation (L. Bestilny, The University of Calgary, Cal-
gary, Alberta, Canada), although a basal level of cell arable level of regulation affecting other components of
the enzyme (Avilion et al., 1996; Blasco et al., 1996;division was occurring in the populations that were ana-
lyzed. This lack of a simple correlation between prolifer- Broccoli et al., 1996). Therefore, cloning of these other
enzyme subunits, as well as potential regulators of geneation and thepresence of telomerase activity may reflect
differences between tumor cells and normal stem cells expression or enzyme activity, will be necessary to fully
understand the complexities of mammalian telomeraseand/or the multiple routes that can lead to the G0 state.
A combination of evidence suggests that activation of regulation. Bryant Villeaponteau (Geron Corporation,
Menlo Park, California) described a molecular approachtelomerase in immortal cell lines involves the mutational
inactivation of the pathway by which telomerase is re- based on a combination of subtractive and differential
expression techniques that has led to a human candi-pressed in most normal somatic cells. This evidence
includes the low frequency of immortalization events, date cDNA that is undetectable in telomerase-minus
cells but is up-regulated in most telomerase-plus cellthe repression of telomerase in hybrids between normal
and immortal cells or cells from different immortalization lines. In a functional assay, expression of a portion of
this transcript confers a dominant negative phenotypecomplementation groups (R. Reddel, Children’s Medical
Research Institute, New South Wales, Australia; T. Ide, on telomere length, consistent with a role for this protein
in telomere length regulation, either as a component ofHiroshima University School of Medicine, Hiroshima, Ja-
pan) and the demonstration that individual chromo- telomerase or possibly as a positive regulator of the
enzyme.somes (3p and 1q; C. Barrett, National Institute of Envi-
ronmental Health Sciences, Research Triangle Park, Finally, increasing evidence indicates that there is a
separate independent pathway for telomere lengthNorth Carolina; M. Oshimura, Tottori University, Tottori,
Japan) can repress telomerase in certain immortal cells. maintenance that does not require telomerase (Kim et
al., 1994; Bryan et al., 1995). A substantial number ofThis strongly implies the existence of two independent
mechanisms for the regulation of telomerase, since the immortalized lines have now been identified with no
detectable telomerase activity and nonoticeable growthpostulated mutation in the pathway for the “permanent”
repression of telomerase in immortal cell lines does not defects (R. Reddel; T. Ide). Strikingly, despite the ab-
sence of enzyme activity, these human cell lines areaffect the ability of those cells to repress telomerase
when they become quiescent. However, even in immor- characterized by very long telomeres (up to 50 kb, ap-
proximately 30 kb longer than that observed in the lon-tal telomerase-positive cell lines which have pre-
sumably undergone a mutational event to allow de- gest telomerase-positive cell lines). This indicates an
additional telomere elongation mechanism, with poten-repression of telomerase, there can still be dynamic and
substantial fluctuations in the level of the enzyme. This tial similarities to telomerase-independent pathways
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that maintain the telomere and cell viability in budding a chromosomal end marked by an integrated plasmid
marker by Southern analysis (Murnane et al., 1994).yeast (Lundblad and Blackburn, 1993; McEachern and
Blackburn, 1996). Analysis of somatic cell hybrids be- Clonal analysis of a telomerase-positive cell line which is
also p531 shows that telomere length varies only slightlytween telomerase-positive cell lines and cell lines exhib-
iting this alternative pathway raised the question of around an optimal mean length (J. Murnane, University
of California, San Francisco, California), similar to thewhether at least some of the genetic factors involved in
the regulation of these two pathways may be shared observations described above for yeast. However, in a
p532 cell line, telomeres show substantial deviation from(R. Reddel). Of critical importance to the future use of
telomerase inhibitors as an anti-cancer therapeutic is this optimal mean length, indicating that one factor in-
volved in the genomic instability observed in p532 cellthe question of whether this alternative means of solving
the end replication problem will also occur in vivo. This lines is a disruption of telomere homeostasis.
correlation between very long telomeres and an alterna-
tive pathway may also relate to the discrepancy in telo- Telomere Shortening in AIDS
mere length that is observed between two closely re- Normal T lymphocyte telomeres shorten as a function
lated species of mice: M. musculus has telomere lengths of donor age in spite of telomerase activity in the hema-
up to 50 kb (Kipling and Cooke, 1990; Starling et al., topoietic system. This has raised questions about
1990), whereas telomere length in the interfertile species whether cellular senescence could play a role in immune
M. spretus is more in the range observed in humans failure following the increased cell turnover caused by
(Prowse and Greider, 1995). The availability of the mouse HIV. A significant decrease in the telomere length of
telomerase RNA (Blasco et al., 1995) will provide an CD81 CD282 T cells was found in HIV-positive patients
important tool in the genetic dissection of the potential (C.-P. Chiu), although no change was found in this study
contribution of this alternative pathway in vivo. for unfractionated CD41 lymphocytes. However, it is pre-
cisely the CD41 cells that have been found to turn over
the most rapidly in AIDS patients (z5% per day). AnotherTelomere Length Homeostasis
report, using many fewer patients, did find a correlationIn all species studied to date, there is a species-specific
between telomere length shortening in CD41 cells indetermination of telomere length, and newly formed
patients with rapidly progressing AIDS versus those withtelomeres in a telomerase-positive cell generally match
a relatively stable disease course (D. Dimitrov, Nationalthe length of bulk endogenous telomeres. However, al-
Cancer Institute, National Institutes of Health, Bethesda,though there is an overall upper and lower limit on telo-
Maryland). More work is clearly needed to resolve issuesmere length, a hallmark of telomeres in most species is
of which lymphocytes show telomere erosion duringlength heterogeneity. Clonal analysis of telomere length
HIV infection and whether or not cellular senescencein budding yeast showed length changes occurring for
of some class of lymphocytes actually contributes toa single telomeric end (Shampay and Blackburn, 1988),
disease progression. The fact that CD41 lymphocytessuggesting that even in an organism that is constitutively
do not show accelerated telomere shortening in mosttelomerase-positive and immortal, there is a dynamic
cases raises questions of the relationship between telo-balance between lengthening and shortening activities.
mere length maintenance and turnover of these cells. ItIn multicellular organisms, the absence of telomerase
is possible that HIV-infected CD41 cells are cleared fromin normal tissues is presumed to be able to eventually
the circulation prior to undergoing many cell divisions;influence proliferative capacity, but telomere length het-
alternatively, HIV infection may affect the functional levelerogeneity raises the issue of whether there are “rate-
of telomerase in these cells to levels that prevent telo-limiting” chromosomes with particularly short telo-
mere shortening. Last but not least, given that acceler-meres. In the murine species M. musculus, this question
ated telomere shortening is observed only in CD81 cellstakes on added importance, because the exceptionally
fractionated based on CD28 expression, identificationlong telomeres in this species challenges the concept
of the appropriate markers may reveal cellular senes-of telomere length as a mitotic clock. One means of
cence of CD41 cells.addressing this issue was provided by M. Zijlmans and
P. Lansdorp (Terry Fox Laboratory, Vancover, British
Columbia), who used the increased hybrid stability of Clinical Uses of Telomerase Assays
The observation that many proliferating “stem” cells canpeptide nucleic acid–DNA heteroduplexes to develop a
quantitative fluorescence in situ hybridization method express telomerase raises many questions about the
postulated role of cellular senescence as an anticancerfor examining the telomere length of individual murine
chromosomes. Preliminary findings indicate that as mechanism, the necessity of telomerase reactivation for
tumor formation, and the utility of telomerase assaysmuch as a ten-fold difference in signal could be
observed between different telomeres in individual for diagnosis/prognosis. Although clear answers have
not yet emerged, a large number of presentations pro-cells; these differences were nonrandomly distributed,
whereas the signal intensity between sister chromatids vided information that addressed these issues, particu-
larly for its use in clinical applications.was highly reproducible. This suggests the opportunity
in the near future to rapidly quantitate the length of A low level of telomerase activity by itself clearly does
not indicate the presence of cancer. Cells of severalevery chromosomal terminus in individual cells, thereby
greatly expanding the level of detailed information on regenerative tissues including the hematopoietic sys-
tems (K. Hiyama, Hiroshima University School of Medi-telomere length control. An alternative approach to the
analysis of mammalian telomere dynamics is to follow cine, Hiroshima, Japan; C.-P. Chiu; K. Buchovich; N.-P.
Cell
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Weng), crypt cells in the intestine (E. Hiyama, Hiroshima California) showed that levels of hTR in neuroblastoma
were as usefulas telomerase levels for predicting patientUniversity School of Medicine, Hiroshima, Japan) and
the basal cells of the skin and transit amplifying cells of survival in childhood neuroblastoma. Levels of the
mouse telomerase RNA component had also beenthe hair follicle (S. Taylor, University of Texas Southwest-
ern Medical Center, Dallas, Texas) have been shown to shown to increase in mouse tumor models accompa-
nying early tumor formation and hyperproliferation, evenexpress telomerase. In lymphocytes, telomere length
has been shown to shorten as a function of donor age. before telomerase levels increased (Blasco et al., 1996;
T. de Lange). These hints that the hTR level might beThis suggests a regulated activity that is sufficient to
slow the rate of shortening but not completely prevent informative were confirmed by in situ hybridization stud-
ies using hTR as a probe, in which dramatic increasesit, so that the proliferative capacity of these cells is
extending without making them immortal. In other in signal strength were found in tumor cells versus the
surrounding normal tissues (N.-W. Kim; J. Shay; E. Ta-cases, low levels of telomerase activity can be ascribed
to the presence of activated lymphocytes (collagen lung, hara, Hiroshima University School of Medicine, Hiro-
shima, Japan). These initial studies found much highersystemic lupus erythematosus, dermatiomyositis, rheu-
matoid arthritis [K. Hiyama], psoriasis, poison ivy [S. levels in the tumor cells than in the crypts of the intestine
or the germinal centers of lymph nodes (areas whereTaylor], cirrhosis, chronic or acute hepatitis [H. Tahara,
Hiroshima University School of Medicine, Hiroshima, Ja- weak telomerase activity had previously been shown to
occur due toactivated lymphocytes or proliferating stempan]). One particular interesting example was the stom-
ach, in which 30% of normal biopsies had telomerase cells). This suggests that in situ hybridization studies
using the telomerase RNA as a probe may help resolveactivity (H. Tahara). However, all of these “normal”
biopsies exhibited metaplasia, and approximately 75% many of the outstanding questions regarding the relative
contributions of inflammatory cells, proliferating stemcontained large numbers of H. pyloris, consistent with
telomerase activity being contributed from both inflam- cells, and tissue cellularity in the diagnosis/prognosis
of tumor biopsies.matory cells and excessive proliferation of stem cells.
In other examples, low level telomerase activity is likely
to represent proliferating stem cells, as in chronically Future Perspectives
The results presented at this meeting indicated thatsun exposed skin (S. Taylor) or benign breast fibroade-
nomas (L. Gollahan, University of Texas Southwestern there are many more levels of regulation of telomerase
activity and telomere length than initially suspected.Medical Center, Dallas, Texas).
Although very low levels of telomerase activity do not Analysis of the mouse and human telomerase RNA com-
ponents has already shown developmental and tissue-necessarily indicate the presence of cancer cells, high
levels of telomerase have been found toshow significant specific regulation, as well as increased expression dur-
ing tumor proliferation. As the genes encoding both thecorrelation with patient survival in a number of cancers,
such as neuroblastoma and colon cancer (E. Hiyama) hypothesized telomerase inhibitor and protein subunits
of the human enzyme are cloned, a detailed molecularand meningioma (J. Shay, University of Texas South-
western Medical Center, Dallas, Texas). In an initial dissection of the pattern of expression of these addi-
tional components will become possible, revealing theirstudy, telomerase levels had prognostic value for node
negative but not node positive breast cancer (G. Roos, potential contributions to telomerase regulation. An ad-
ditional critical experiment will be a direct in vivo testUmea University, Umea, Sweden). However, the results
for node positive breast cancer were called into question of the hypothesis that telomerase reactivation is an
obligatory step in oncogenesis, via genetic manipula-by Nam-Woo Kim (Geron Corporation, Menlo Park, Cali-
fornia). Although only a very weak risk factor of about tions to ask first, if tumor progression is impaired when
telomerase genes are inactivated and second, if tumor1.4 was associated with an uncorrected telomerase level
for node positive patients, the risk factor increased 20- formation can be promoted when telomerase expres-
sion is turned on in normal tissues. Crucial to the under-fold if the results were normalized to a measure for
viable tissue cellularity. This suggests that the already standing of these experimental alterations in telomerase
expression will be a more detailed understanding of theimpressive evidence that telomerase assays will have
important clinical applications will likely get stronger as potential contribution of alternative telomerase-inde-
pendent pathways. Finally, from the standpoint of themore sophisticated assays become used.
The complicating issues of telomerase from inflamma- basic scientist, the stage is also set for a series of key
experiments, including reconstitution of the enzymetory cells, stem cells and cellularity could clearly be
resolved if in situ techniques for telomerase were avail- from purified components and a molecular investigation
of how telomerase interacts with components of theable. The fact that the human telomerase RNA compo-
nent is expressed in normal diploid cells at 10–30% of telosome.
In spite of the complexities of telomerase regulation,the level in cancer cell lines (Avilion et al., 1996) initially
discouraged its use as a probe. However, the observa- the clinical reports presented at this meeting continued
tosupport the initialenthusiasm for the diagnostic, prog-tion that telomerase activity is repressed in most quies-
cent cells but increased upon proliferation (discussed nostic, and therapeutic uses of telomerase assays and
potential telomerase inhibitors. The original all-or-noneabove) raised the possibility that the RNA component
might also be down regulated, so that the background assessment of telomerase activity in cancer versus nor-
mal cells has proven to be an oversimplification, indicat-from quiescent normal cells might be low. C. Patrick
Reynolds (Children’s Hospital of Los Angeles, University ing that an increasingly sophisticated analysis of telo-
merase levels will be required for meaningful clinicalof Southern California School of Medicine, Los Angeles,
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Henderson, E. (1995). Telomere DNA structure. In Telomeres, E.H.interpretations. However, the clinical studies continue
Blackburn and C. W. Greider, eds. (Cold Spring Harbor, New York:to show both the value of telomerase as a tumor marker
Cold Spring Harbor Laboratory Press), pp. 11–34.and the ways in which knowledge about telomerase
Kim, N.W., Piatyszek, M.A., Prowse, K.R., Harley, C.B., West, M.D.,activity can be used to aid clinicians in their care of
Ho, P. L. C., Coviello, G.M., Wright, W.E., Weinrich, S.L., and Shay,
cancer patients. J.W. (1994). Specific association of human telomerase activity with
immortal cells and cancer. Science 266, 2011–2015.
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